ProCE Continuing Education

11/26/2025

❗IMPORTANT: This page will soon be deactivated. Please follow Decera Clinical Education for all future educational content and updates.

Our new visual identity as Decera Clinical Education (formerly ProCE, CCO, and PCE) will be live in person at . 👀

If you’re at , stop by Booth 142 to learn about our new chapter.

💻 Explore more: https://bit.ly/3X6MU7f

11/21/2025

It’s official! We are now Decera Clinical Education and we’re moving to a new page! ✨

⚠️ Important update: This LinkedIn account will soon be deactivated. To stay connected and continue receiving updates, please follow Decera Clinical Education.

All content and updates you’ve known from ProCE are now part of Decera Clinical Education (deh-SAIR-uh), the unified home for our brands formerly known as CCO, PCE, and ProCE.

Rest assured, with Decera Clinical Education you will continue to experience:

✅ Cutting-edge science and expert-led CME/CE
✅ Free, accredited on-demand activities and live events
✅ Uninterrupted access to your account, course history, and certificates. Your earned credits stay with you.

We are one of three divisions within the Clinical brand, spanning accredited education, actionable insights, and medical communications–all aligned with a shared purpose to advance patient care.

Thank you for joining us in this exciting next chapter.

Learn more → https://deceraclinical.com/education/content/hcp?utm_source=facebook&utm_medium=organic&utm_campaign=Decera%20Clinical_Rebrand_Education_2096&utm_content=&utm_term=

10/30/2025

IMPORTANT UPDATE! ProCE will soon be part of something even bigger!

We’re evolving into Decera Clinical Education (deh-SAIR-uh) — a new name that unites everything you’ve trusted from ProCE Continuing Education, Practicing Clinicians Exchange for NPs & PAs, and Clinical Care Options under one clear identity.

Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.

Under Decera Clinical Education, you’ll continue to enjoy:
✅ Cutting-edge science
✅ Free accredited CME/CE courses taught by expert faculty
✅ Uninterrupted access to your profile using the same login credentials, course history, and certificate information —your earned credits stay with you

This update is part of our ongoing commitment to creating a simpler, more connected experience for healthcare professionals, built on the same scientific rigor and dedication you’ve always known.

⚠️ Please note: Over the coming months, this account will be deactivated as we transition all updates to the Clinical Care Options social channels.

To ensure you don’t miss any news or learning opportunities, follow Clinical Care Options today!

We can’t wait for you to join us in this exciting new chapter together!

05/11/2025

Happening tomorrow! Oncology pharmacists play a vital role in managing ADCs for solid tumors—don’t miss this live webinar.

🎙 Featuring Allison Butts, PharmD, BCOP & Danielle Roman, PharmD, BCOP

✅ Learn how to manage ADC-related adverse events
✅ Strengthen shared decision-making

Join us virtually tomorrow: https://bit.ly/4irDISV

05/07/2025

Join us online for this interactive webinar with pharmacy experts discussing the latest recommendations for optimizing BTK inhibitor–based treatment in patients with chronic lymphocytic leukemia (CLL) including monitoring and managing treatment associated toxicities, evaluating drug–drug interactions, and more!

Join tomorrow, virtually, 12 pm ET:

Join us online for this interactive webinar with pharmacy experts discussing the latest recommendations for optimizing BTK inhibitor–based treatment in patients with chronic lymphocytic leukemia (CLL) including monitoring and managing treatment associated toxicities, evaluating drug–drug interac...

05/01/2025

Precision medicine is evolving—are you up to date?

✨ Oncology pharmacists are playing a critical role in the use of antibody–drug conjugates (ADCs) for solid tumors.

Join us for a live webinar, featuring experts, Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP.

Learn to:
✅ Mitigate ADC-related adverse events
✅ Enhance shared decision-making in care

Register right here: https://bit.ly/4irDISV

04/27/2025

Join us in just a few days for an expert-led discussion on the latest advancements in frontline therapy for chronic-phase CML! 🎙️💊

Leading hematology/oncology pharmacists will break down the newest data on later-generation TKIs, key monitoring strategies, and how to optimize patient care.

Register for our virtual event: https://bit.ly/4hooXQq

04/06/2025

Join us for a 1-hour live webinar on managing HR+/HER2- MBC in patients with comorbidities. Experts will discuss minimizing polypharmacy, avoiding drug interactions, and optimizing care.

📅 Live & Interactive! Register here: https://bit.ly/4hp3MxJ

03/29/2025

Early intervention is key to improving long-term outcomes in moderate to severe Crohn’s disease (CD). With IL-23 inhibitors emerging as powerful biologic therapies, patients can experience rapid symptom relief and durable remission.

Join us for "Hit the Ground Running in Crohn’s Disease: A Managed Care Guide to Advanced Biologic Therapies and Early Interventions"—a program designed to help managed care professionals apply the latest evidence on IL-23 antagonists to optimize patient care.

🔹 Enhance your approach to CD management
🔹 Stay ahead with cutting-edge treatment strategies
🔹 Improve patient outcomes with timely intervention

Join us April 1st: https://bit.ly/3DRKOSw

03/23/2025

Systemic mastocytosis (SM) presents unique challenges for both patients and healthcare providers. With new therapies like KIT inhibitors offering hope beyond symptom management, pharmacists play a crucial role in ensuring safe and effective treatment strategies.

The ProCE Pharmacy Education Series provides the latest insights on SM, equipping pharmacists with the knowledge to optimize patient care and improve outcomes. Don't miss this opportunity to stay ahead!

📅 Join us tomorrow: https://bit.ly/3R3qyjL

03/18/2025

Pharmacists: Are you prepared to tackle the challenges of systemic mastocytosis (SM)?

SM is a complex condition that can significantly impact patients’ lives, with symptoms ranging from anaphylaxis to chronic burden. While traditional management has focused on symptom control, emerging therapies like KIT inhibitors are changing the landscape.

✨ Join the ProCE Pharmacy Education Series to explore pharmacy-focused strategies for improving patient outcomes. Gain key insights on new therapies, safety considerations, and best practices for supporting SM patients.

📅 Register now to stay ahead in SM management! https://bit.ly/3R3qyjL